Cargando…
First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol
INTRODUCTION: Our group has conducted extensive basic and preclinical studies of the use of human induced pluripotent cell (iPSC)-derived neural stem/progenitor cell (hiPSC-NS/PC) grafts in models of spinal cord injury (SCI). Evidence from animal experiments suggests this approach is safe and effect...
Autores principales: | Sugai, Keiko, Sumida, Miho, Shofuda, Tomoko, Yamaguchi, Ryo, Tamura, Takashi, Kohzuki, Tsuneo, Abe, Takayuki, Shibata, Reo, Kamata, Yasuhiro, Ito, Shuhei, Okubo, Toshiki, Tsuji, Osahiko, Nori, Satoshi, Nagoshi, Narihito, Yamanaka, Shinya, Kawamata, Shin, Kanemura, Yonehiro, Nakamura, Masaya, Okano, Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427225/ https://www.ncbi.nlm.nih.gov/pubmed/34522725 http://dx.doi.org/10.1016/j.reth.2021.08.005 |
Ejemplares similares
-
LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury
por: Ito, Shuhei, et al.
Publicado: (2021) -
Regenerative therapy for spinal cord injury using iPSC technology
por: Nagoshi, Narihito, et al.
Publicado: (2020) -
Treatment with a Gamma-Secretase Inhibitor Promotes Functional Recovery in Human iPSC- Derived Transplants for Chronic Spinal Cord Injury
por: Okubo, Toshiki, et al.
Publicado: (2018) -
Cell therapy for spinal cord injury by using human iPSC-derived region-specific neural progenitor cells
por: Kajikawa, Keita, et al.
Publicado: (2020) -
Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury
por: Kitagawa, Takahiro, et al.
Publicado: (2022)